Skip to main content
. 2009 Sep 15;101(8):1417–1424. doi: 10.1038/sj.bjc.6605298

Figure 1.

Figure 1

Alteration of the VHL gene in 102 CCRCC tumours. (A) Distribution of the different VHL alterations identified. (B) Cause-specific survival curve for patients with CCRCC based on VHL alterations (solid line, mutation, deletion or methylation of the VHL gene, n=91, 89.2%; broken line, no VHL alteration, n=11, 10.8%).